Drugs that doctors often use in the treatment of overactive bladder, gastrointestinal conditions, and depression may increase dementia risk by almost half.
New research finds that nilvadipine, a drug doctors commonly use to treat high blood pressure, increases the blood flow to the brain’s hippocampus.
A study of adults aged 50 and over found that decline in memory and thinking was faster after a heart attack or angina, but not before.
Scientists find a key difference between Alzheimer’s and frontotemporal dementia: the latter affects a person’s ‘moral emotions’ while the former does not.
New research asks to what extent, if any, a person’s level of education is linked to the presence of Alzheimer’s disease and the rate of cognitive decline.
A large study analyzing the medical data of thousands of people suggests that dementia incidence is lower among those who take blood pressure medication.
New research suggests that using a virtual reality simulator could be more effective at detecting Alzheimer’s disease than standard tests.
A new study connects high blood levels of ‘bad’ cholesterol with the presence of early-onset Alzheimer’s. The link, the authors suggest, could be causal.
A new study in mice suggests that a combination of antibiotics may reduce the buildup of amyloid plaques, but only in male brains.
New research finds that some Alzheimer’s-related biomarkers in the brain change as early as 34 years before the onset of visible symptoms.
The WHO have recently released a new set of guidelines around strategies for dementia prevention, in which they evaluate potential interventions.
According to a recent study, virtual reality might provide a useful tool for treating dementia. Among other things, it may help improve memory.
A drug that tackles toxic protein buildup in Alzheimer’s disease in a novel way has passed phase 1 of clinical trials, which tests safety in humans.
A study uncovers the neuron and immune cell changes that explain why light therapy can reduce toxic brain proteins in mouse models of Alzheimer’s disease.
According to a new study, a cell phone game called ‘Sea Hero Quest’ could assist researchers in identifying people who are more at risk of Alzheimer’s.
Experts have defined an under-recognized, newly named condition that mimics Alzheimer’s disease and propose guidelines for diagnosing and researching it.
Data from up to 11 years of blood samples confirm neurofilament light protein as a potential noninvasive marker of Alzheimer’s disease progression.
Scientists have designed a protein that folds into alpha sheets that can block toxic beta-amyloid in brain cells before it forms into large clumps.
Using brain scans that can detect hallmarks of Alzheimer’s could improve diagnosis and clinical care of people with dementia and mild cognitive impairment.
Scientists have found that an experimental drug that failed against cancer may treat dementia instead. However, can they test it in clinical trials?